Boston, MA
Boston, MA – 2025 USCAP Meeting Recap
USCAP made its way to Boston in 2025—and what a meeting it was! The historic charm of the “Hub of the Universe” set the perfect stage for a week packed with science, camaraderie, and more than a few bowls of authentic New England clam chowder. And yes, we ate our fair share of lobster—because when in Boston, you simply have to.
The headline of the meeting: the final consensus on myocarditis in both large specimens and endomyocardial biopsies was officially finalized! Years of spirited debate culminated in the creation of the brand-new “Seaport Myocarditis Criteria,” a name chosen in honor of the Boston Seaport district where the hard work came together. This landmark replaces the old Dallas Criteria and—fingers crossed—will slowly win global adoption as the new standard.
As if that milestone weren’t enough, we also hosted our first-ever Pericardial Diseases consensus meeting, led by Dr. Carmela Tan and Dr. E. Rene Rodriguez., marking the start of another exciting chapter in cardiovascular pathology.
The scientific sessions were stellar, the presenters inspiring, and the energy electric. A special highlight was the Distinguished Achievement Award ceremony honoring Dr. Cristina Basso. Surrounded by colleagues and friends, she was clearly moved by the heartfelt tributes and the warm celebration of her extraordinary contributions.
Leadership passed seamlessly as Dr. Giulia d’Amati took the helm as our new president, while Dr. Joe Malazheski stepped down after an exceptional term—thank you, Joe, for your remarkable leadership and vision.
On the pages of Cardiovascular Pathology, another significant transition deserves recognition. After twelve years of distinguished service as Editor-in-Chief, Dr. L. Maximilian Buja steps down from this role, leaving behind a journal transformed by his vision, dedication, and scholarly rigor. Under his leadership, Cardiovascular Pathology grew in scientific impact, international reach, and editorial excellence — remaining the premier international forum for cardiovascular pathology scholarship. We are deeply grateful for his twelve years of tireless service and dedication to this publication. The journal he leaves behind stands as a lasting testament to his contributions. We warmly welcome Dr. Joseph Maleszewski as incoming Editor-in-Chief, and we look forward with confidence to the next chapter of Cardiovascular Pathology under his leadership.
Next stop: San Antonio, Texas, in 2026! Get ready to trade clam chowder for brisket and lobster rolls for barbecue—because everything (including the science and the fun) really is bigger in Texas.
